Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artacent in Chronic Diabetic Foot Ulcers
NCT04457752Phase 4Unknown
- Sponsor
- SerenaGroup
- Start
- Sep 2020
- Primary completion
- Mar 2022
- Modality
- Biologic
- Countries
- 2
01
Overview
A Phase 4 trial of Artacent in diabetic foot ulcer (DFU), sponsored by SerenaGroup. Status: unknown.
02
Drugs
Artacent
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT04457752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04457752.